Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Vaccines

Free Subscription Articles published in Virus Res Retrieve available abstracts of 32 articles: HTML format

Single Articles

July 2022
1. LI J, Li S, Qiu M, Li X, et al
   Minor and major envelope proteins of PRRSV play synergistic roles in inducing heterologous neutralizing antibodies and conferring cross protection.
   Virus Res. 2022;315:198789.
   PubMed     Abstract available
   
   
   June 2022
2. GONG Y, Sui L, Li Y
   Recombination in Papillomavirus: Controversy and Possibility.
   Virus Res. 2022;314:198756.
   PubMed     Abstract available
   
   
   May 2022
3. JUNG MH, Nikapitiya C, Kim SJ, Han HJ, et al
   Protective immunity induced by ankyrin repeat-containing protein-based DNA vaccine against rock bream iridovirus (RBIV) in rock bream (Oplegnathus fasciatus).
   Virus Res. 2022 May 26:198827. doi: 10.1016/j.virusres.2022.198827.
   PubMed     Abstract available
   
   
   
4. ROWLAND RRR, Doerksen T, Lu A, Sheahan M, et al
   Effect of the host genotype at a Porcine Reproductive and Respiratory Syndrome (PRRS) resistance marker on evolution of the modified-live PRRS vaccine virus in pigs.
   Virus Res. 2022;316:198809.
   PubMed     Abstract available
   
   
   April 2022
5. ALMEIDA F, Santos LA, Trigueiro-Louro JM, RebelodeAndrade H, et al
   Optimization of A(H1N1)pdm09 vaccine seed viruses: the source of PB1 and HA vRNA as a major determinant for antigen yield.
   Virus Res. 2022 Apr 30:198795. doi: 10.1016/j.virusres.2022.198795.
   PubMed     Abstract available
   
   
   
6. WEI N, Wang Q, Lin Z, Xu L, et al
   Systematic profiling of antigen bias in humoral response against SARS-CoV-2.
   Virus Res. 2022;312:198711.
   PubMed     Abstract available
   
   
   March 2022
7. SILVA LMN, Santos MR, Carvalho JA, Carvalho OV, et al
   Molecular analysis of the full-length VP2 gene of Brazilian strains of canine parvovirus 2 shows genetic and structural variability between wild and vaccine strains.
   Virus Res. 2022 Mar 12:198746. doi: 10.1016/j.virusres.2022.198746.
   PubMed     Abstract available
   
   
   
8. XU M, Zhang C, Liu Y, Chen S, et al
   A noval strategy of deletion in PK gene for construction of a vaccine candidate with exellent safety and complete protection efficiency against high virulent Chinese pseudorabies virus variant.
   Virus Res. 2022 Mar 7:198740. doi: 10.1016/j.virusres.2022.198740.
   PubMed     Abstract available
   
   
   
9. AGBLA JM, Esona MD, Jaimes J, Gautam R, et al
   Whole genome analysis of rotavirus strains circulating in Benin before vaccine introduction, 2016-2018.
   Virus Res. 2022 Mar 2:198715. doi: 10.1016/j.virusres.2022.198715.
   PubMed     Abstract available
   
   
   January 2022
10. PERBOLIANACHIS P, Ferla D, Arce R, Ferreiro I, et al
    Phylogenetic analysis of SARS-CoV-2 viruses circulating in the South American region: genetic relations and vaccine strain match.
    Virus Res. 2022 Jan 21:198688. doi: 10.1016/j.virusres.2022.198688.
    PubMed     Abstract available
    
    
    November 2021
11. XIAO T, Leng H, Zhang Q, Chen Q, et al
    Isolation and characterization of a Sabin 3/Sabin 1 recombinant vaccine-derived poliovirus from a child with severe combined immunodeficiency.
    Virus Res. 2021 Nov 15:198633. doi: 10.1016/j.virusres.2021.198633.
    PubMed     Abstract available
    
    
    
12. SUN Y, Li C, Li Z, Shangguan A, et al
    Quercetin as an antiviral agent inhibits the Pseudorabies virus in vitro and in vivo.
    Virus Res. 2021;305:198556.
    PubMed     Abstract available
    
    
    September 2021
13. LEI H, Li S, Lu X, Ren Y, et al
    Oral administration of Saccharomyces cerevisiae displaying VP28-VP24 confers protection against white spot syndrome virus in shrimp.
    Virus Res. 2021;302:198467.
    PubMed     Abstract available
    
    
    August 2021
14. HU J, Li G, Xi W, Cai L, et al
    Development of a subunit vaccine based on fiber2 and hexon against fowl adenovirus serotype 4.
    Virus Res. 2021 Aug 26:198552. doi: 10.1016/j.virusres.2021.198552.
    PubMed     Abstract available
    
    
    July 2021
15. RAYCHOUDHURI A, Naru AK, Kanubothula SR, Uddala R, et al
    Development of an experimental inactivated vaccine from Vero cell adapted Enterovirus D68.
    Virus Res. 2021 Jul 30:198528. doi: 10.1016/j.virusres.2021.198528.
    PubMed     Abstract available
    
    
    June 2021
16. DOERFLER W
    Viral Vector DNA- and RNA-Based SARS-CoV-2 Vaccines: Possible Integration into the Human Genome Are Adenoviral Genes Expressed in Vector-based Vaccines?
    Virus Res. 2021 Jun 1:198466. doi: 10.1016/j.virusres.2021.198466.
    PubMed     Abstract available
    
    
    
17. LEI L, Qin H, Luo J, Tan Y, et al
    Construction and immunological evaluation of hepatitis B virus core virus-like particles containing multiple antigenic peptides of respiratory syncytial virus.
    Virus Res. 2021;298:198410.
    PubMed     Abstract available
    
    
    May 2021
18. CARNEIRO DC, Sousa JD, Monteiro-Cunha JP
    The COVID-19 Vaccine Development: A Pandemic Paradigm.
    Virus Res. 2021 May 17:198454. doi: 10.1016/j.virusres.2021.198454.
    PubMed     Abstract available
    
    
    
19. BIDART J, Mignaqui A, Kornuta C, Lupi G, et al
    FMD empty capsids combined with the Immunostant Particle Adjuvant -ISPA or ISA206 induce protective immunity against foot and mouth disease virus.
    Virus Res. 2021;297:198339.
    PubMed     Abstract available
    
    
    April 2021
20. YAN Z, Chen M, Tang D, Wu X, et al
    Better immune efficacy triggered by the inactivated gI/gE-deleted pseudorabies virus with the additional insertion of gC gene in mice and weaned pigs.
    Virus Res. 2021;296:198353.
    PubMed     Abstract available
    
    
    
21. ROY S, Ghani K, de Campos-Lima PO, Caruso M, et al
    A stable platform for the production of virus-like particles pseudotyped with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike protein.
    Virus Res. 2021;295:198305.
    PubMed     Abstract available
    
    
    
22. HU Z, Zhao J, Shi L, Hu J, et al
    Identification of the dominant non-neutralizing epitope in the haemagglutinin of H7N9 avian influenza virus.
    Virus Res. 2021;298:198409.
    PubMed     Abstract available
    
    
    
23. KANAI Y, Kobayashi T
    Rotavirus reverse genetics systems: Development and application.
    Virus Res. 2021;295:198296.
    PubMed     Abstract available
    
    
    March 2021
24. LARIJANI MS, Ramezani A, Shirazi MMA, Bolhassani A, et al
    Evaluation of transduced dendritic cells expressing HIV-1 p24-Nef antigens in HIV-specific cytotoxic T cells induction as a therapeutic candidate vaccine.
    Virus Res. 2021 Mar 25:198403. doi: 10.1016/j.virusres.2021.198403.
    PubMed     Abstract available
    
    
    
25. LANDGRAF G, Desheva YA, Rudenko LG
    Evaluation of influenza A and B cold-adapted reassortant virus reproduction in trivalent live influenza vaccines.
    Virus Res. 2021 Mar 17:198396. doi: 10.1016/j.virusres.2021.198396.
    PubMed     Abstract available
    
    
    
26. FEARON SH, Dennis SJ, Hitzeroth II, Rybicki EP, et al
    Humoral and cell-mediated immune responses to plant-produced African horse sickness virus VP7 quasi-crystals.
    Virus Res. 2021;294:198284.
    PubMed     Abstract available
    
    
    
27. KOTAKI T, Yamanaka A, Konishi E, Kameoka M, et al
    A potent neutralizing mouse monoclonal antibody specific to dengue virus type 1 Mochizuki strain recognized a novel epitope around the N-67 glycan on the envelope protein: A possible explanation of dengue virus evolution regarding the acquisition of N
    Virus Res. 2021;294:198278.
    PubMed     Abstract available
    
    
    January 2021
28. ANWAR MN, Guo S, Xin W, Hameed M, et al
    Adaptation of a live-attenuated genotype I Japanese encephalitis virus to vero cells is associated with mutations in structural protein genes.
    Virus Res. 2021;292:198256.
    PubMed     Abstract available
    
    
    November 2020
29. KIM SW, Kim SJ, Oh MJ
    Efficacy of live NNV immersion vaccine immunized at low temperature in sevenband grouper, Epinephelus septemfasciatus.
    Virus Res. 2020 Nov 10:198227. doi: 10.1016/j.virusres.2020.198227.
    PubMed     Abstract available
    
    
    October 2020
30. SITARAS I, Spackman E, de Jong MCM, Parris DJ, et al
    Selection and Antigenic Characterization of Immune-Escape Mutants of H7N2 Low Pathogenic Avian Influenza Virus Using Homologous Polyclonal Sera.
    Virus Res. 2020 Oct 9:198188. doi: 10.1016/j.virusres.2020.198188.
    PubMed     Abstract available
    
    
    August 2020
31. WENJUN M
    Swine Influenza Virus: Current Status and Challenge.
    Virus Res. 2020 Aug 13:198118. doi: 10.1016/j.virusres.2020.198118.
    PubMed     Abstract available
    
    
    June 2020
32. GAO X, Zhao D, Zhou P, Zhang L, et al
    Characterization, pathogenicity and protective efficacy of a cell culture-derived porcine deltacoronavirus.
    Virus Res. 2020;282:197955.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: